Laurus Labs Limited
Laurus Labs Limited (LAURUSLABS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
lauruslabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹1868.50
Market cap
1,00,861 Cr
Stock P/E
87.9
P/B
18.57
Dividend yield
0.1%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,224 Cr | 1,195 Cr | 1,440 Cr | 1,195 Cr | 1,224 Cr | 1,415 Cr | 1,720 Cr | 1,570 Cr | 1,653 Cr | 1,778 Cr | 1,812 Cr | 2,026 Cr |
| Operating expenses (approx.) | 1,037 Cr | 1,014 Cr | 1,198 Cr | 1,024 Cr | 1,045 Cr | 1,130 Cr | 1,300 Cr | 1,187 Cr | 1,250 Cr | 1,298 Cr | 1,299 Cr | 1,388 Cr |
| EBITDA | 188 Cr | 181 Cr | 241 Cr | 171 Cr | 178 Cr | 285 Cr | 421 Cr | 382 Cr | 403 Cr | 480 Cr | 512 Cr | 638 Cr |
| OPM % | 15.3% | 15.2% | 16.8% | 14.3% | 14.6% | 20.2% | 24.4% | 24.3% | 24.4% | 27.0% | 28.3% | 31.5% |
| Other income | 2 Cr | 2 Cr | 19 Cr | 3 Cr | 5 Cr | 9 Cr | 59 Cr | 10 Cr | 27 Cr | 6 Cr | 12 Cr | 9 Cr |
| Interest | 42 Cr | 51 Cr | 51 Cr | 49 Cr | 53 Cr | 58 Cr | 56 Cr | 52 Cr | 40 Cr | 39 Cr | 40 Cr | 42 Cr |
| Depreciation | 93 Cr | 98 Cr | 102 Cr | 106 Cr | 108 Cr | 106 Cr | 110 Cr | 117 Cr | 120 Cr | 121 Cr | 122 Cr | 124 Cr |
| Profit before tax | 52 Cr | 33 Cr | 107 Cr | 19 Cr | 25 Cr | 133 Cr | 311 Cr | 225 Cr | 270 Cr | 325 Cr | 362 Cr | 481 Cr |
| Tax % | 28.2% | 28.8% | 29.9% | 33.0% | 20.3% | 30.1% | 25.2% | 28.1% | 28.1% | 22.6% | 22.0% | 24.8% |
| Net profit | 37 Cr | 23 Cr | 75 Cr | 13 Cr | 20 Cr | 93 Cr | 233 Cr | 162 Cr | 194 Cr | 252 Cr | 282 Cr | 362 Cr |
| EPS (₹) | ₹0.69 | ₹0.43 | ₹1.40 | ₹0.23 | ₹0.37 | ₹1.71 | ₹4.34 | ₹3.02 | ₹3.61 | ₹4.67 | ₹5.17 | ₹6.81 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,292 Cr | 2,832 Cr | 4,814 Cr | 4,936 Cr | 6,041 Cr | 5,041 Cr | 5,554 Cr | 6,813 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,936 Cr | 2,267 Cr | 3,263 Cr | 3,513 Cr | 4,448 Cr | 4,263 Cr | 4,499 Cr | 5,035 Cr | Sign in for TTM |
| EBITDA | 356 Cr | 565 Cr | 1,551 Cr | 1,422 Cr | 1,592 Cr | 778 Cr | 1,055 Cr | 1,778 Cr | Sign in for TTM |
| OPM % | 15.5% | 19.9% | 32.2% | 28.8% | 26.4% | 15.4% | 19.0% | 26.1% | Sign in for TTM |
| Other income | 16 Cr | 6 Cr | 24 Cr | 15 Cr | 6 Cr | 26 Cr | 75 Cr | 55 Cr | Sign in for TTM |
| Interest | 88 Cr | 90 Cr | 68 Cr | 102 Cr | 165 Cr | 183 Cr | 216 Cr | 171 Cr | Sign in for TTM |
| Depreciation | 164 Cr | 187 Cr | 205 Cr | 251 Cr | 324 Cr | 385 Cr | 430 Cr | 480 Cr | Sign in for TTM |
| Profit before tax | 120 Cr | 294 Cr | 1,301 Cr | 1,084 Cr | 1,106 Cr | 230 Cr | 488 Cr | 1,182 Cr | Sign in for TTM |
| Tax % | 21.7% | 13.1% | 24.4% | 23.2% | 28.2% | 29.6% | 26.6% | 24.7% | Sign in for TTM |
| Net profit | 94 Cr | 255 Cr | 984 Cr | 832 Cr | 793 Cr | 162 Cr | 358 Cr | 890 Cr | Sign in for TTM |
| EPS (₹) | ₹8.83 | ₹23.93 | ₹18.36 | ₹15.42 | ₹14.69 | ₹2.98 | ₹6.65 | ₹16.47 | Sign in for TTM |
| Dividend payout % | — | — | — | 10.3% | 13.5% | 53.1% | 12.0% | 9.7% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 106 Cr | 107 Cr | 107 Cr | 107 Cr | 108 Cr | 108 Cr | 108 Cr | 108 Cr |
| Reserves | 1,452 Cr | 1,663 Cr | 2,490 Cr | 3,244 Cr | 3,930 Cr | 4,003 Cr | 4,365 Cr | 5,192 Cr |
| Borrowings | 943 Cr | 956 Cr | 1,315 Cr | 1,732 Cr | 1,972 Cr | 2,507 Cr | 2,693 Cr | 2,397 Cr |
| Other liabilities | 830 Cr | 1,025 Cr | 1,835 Cr | 1,877 Cr | 1,640 Cr | 1,764 Cr | 2,040 Cr | 2,682 Cr |
| Total liabilities | 3,331 Cr | 3,750 Cr | 5,751 Cr | 6,968 Cr | 7,660 Cr | 8,387 Cr | 9,336 Cr | 10,511 Cr |
| Fixed assets (net) | 1,607 Cr | 1,664 Cr | 1,860 Cr | 2,257 Cr | 3,016 Cr | 3,446 Cr | 3,668 Cr | 3,873 Cr |
| CWIP | 110 Cr | 67 Cr | 362 Cr | 813 Cr | 551 Cr | 423 Cr | 458 Cr | 773 Cr |
| Investments | 3 Cr | 46 Cr | 59 Cr | 169 Cr | 183 Cr | 302 Cr | 233 Cr | 309 Cr |
| Loans & advances | 0.42 Cr | 0.49 Cr | 0.68 Cr | 0.64 Cr | 0.97 Cr | 0.95 Cr | 0.93 Cr | 0.93 Cr |
| Inventories | 682 Cr | 905 Cr | 1,575 Cr | 1,760 Cr | 1,685 Cr | 1,845 Cr | 1,937 Cr | 2,342 Cr |
| Trade receivables | 710 Cr | 791 Cr | 1,306 Cr | 1,354 Cr | 1,580 Cr | 1,663 Cr | 2,007 Cr | 2,155 Cr |
| Cash & bank | 3 Cr | 2 Cr | 48 Cr | 75 Cr | 46 Cr | 139 Cr | 100 Cr | 113 Cr |
| Other assets | 216 Cr | 274 Cr | 539 Cr | 538 Cr | 598 Cr | 567 Cr | 931 Cr | 945 Cr |
| Total assets | 3,331 Cr | 3,750 Cr | 5,751 Cr | 6,968 Cr | 7,660 Cr | 8,387 Cr | 9,336 Cr | 10,511 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 911 Cr | 994 Cr | 666 Cr | 602 Cr | 1,624 Cr |
| Cash from investing | — | — | — | -914 Cr | -996 Cr | -822 Cr | -682 Cr | -1,089 Cr |
| Cash from financing | — | — | — | 30 Cr | -27 Cr | 250 Cr | 39 Cr | -525 Cr |
| Net cash flow | — | — | — | 27 Cr | -30 Cr | 93 Cr | -39 Cr | 13 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 34 Cr | 4 Cr | -13 Cr | -39 Cr | 554 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 8.3% | 14.1% | 35.0% | 23.3% | 21.1% | 6.2% | 9.7% | 17.3% |
| ROE % | 6.3% | 15.8% | 44.9% | 27.7% | 19.5% | 3.9% | 7.8% | 16.4% |
| Debtor days | 113 | 102 | 99 | 100 | 95 | 120 | 132 | 115 |
| Inventory days | 199 | 205 | 243 | 282 | 236 | 278 | 290 | 305 |
| Days payable | 143 | 139 | 182 | 141 | 100 | 158 | 144 | 163 |
| Cash conversion cycle | 169 | 168 | 160 | 242 | 232 | 240 | 278 | 257 |
| Debt / equity | 0.61 | 0.00 | 0.00 | 0.00 | 0.49 | 0.61 | 0.60 | 0.45 |
| Current ratio | 1.03 | 1.07 | 1.25 | 1.25 | 1.42 | 1.23 | 1.22 | 1.33 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.21 | 3.05 | 2.46 | 1.29 |
Compare with peers
Loading peers…